HPV-based Screening Among Women 23-29 Years of Age
Recruiting
N/A
Interventional Study
Human Papilloma Virus
Cervical Intraepithelial Neoplasia
Cervical Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 23 – 29
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 180,000 (estimated)
- Sponsor
- Karolinska Institutet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women ages 23-29 invited to screening.
Exclusion Criteria:
* Women who do not show up for screening or do not consent.
Contacts